Preparing for the 2025 US Presidential Administration

Overview

As President-elect Donald Trump prepares to take office, organizations can stay ahead of US policy changes and strategic shifts that may impact operations under the new presidential administration. McDermott’s cross-practice team, along with health policy consultancy McDermott+, is providing timely analysis and proactive guidance across key sectors, including regulatory enforcement, healthcare, antitrust, and more.

Refer to our curated collection of articles, webinars, and commentary below to help you understand the implications of the new administration’s policies and prepare for the evolving regulatory landscape.

INSIGHTS

First 100 Days Resource Center: McDermott+ shares commentary and analysis on the most pertinent emerging topics related to the healthcare landscape and how they may impact your business throughout the first half of 2025.

Data Privacy and Cybersecurity Developments We Are Watching in 2025: What will the second Trump administration bring when it comes to federal consumer privacy regulation? Between chatter of shuttering entire agencies and shifting enforcement priorities, it is clear that this year will see a change in the way that the federal government approaches its role in the consumer privacy arena.

How Cross-Border M&A May Be Impacted by Incoming Tax Reform: President-elect Trump did not present a formal tax proposal during his campaign, but he highlighted key areas of tax policy that will impact individuals and businesses, with significant implications for cross-border mergers and acquisitions.

AI and the Law: Emerging Trends in Enforcement: The US federal government has taken various steps to address the rapid development and deployment of AI technologies, with recent actions by federal and state regulators offering insights into AI enforcement priorities.

Peering Into the Crystal Ball: Crypto Enforcement in a Second Trump Term: The reelection of President-elect Trump – who has signaled an intention to substantially reduce regulatory scrutiny over crypto – will change recent crypto enforcement priorities, as well as the governmental entities and units advancing them.

Post-Election Outlook: Pharmacy Regulation: There are important implications for the outlook for pharmacy regulation under the second incoming Trump administration and a unified Republican Congress, as well as state-level pharmacy policies that may advance as Republican public policy momentum builds.

What a Second Trump Term Means for Antitrust Enforcement: While it appears that the new administration will be good for business, especially for companies planning to expand through mergers and acquisitions, this client alert examines what is likely to change and what is likely to stay the same in antitrust enforcement throughout the next four years.

Lame Duck 2024 Update: Healthcare Priorities: With Republicans controlling the White House, US Senate, and US House of Representatives in 2025, each side will need to consider whether negotiating a compromise during the lame duck session is ultimately politically better than what they could achieve next year.

WEBINARS AND EVENTS

2025 Enforcement Outlook | The Trump Administration’s Regulatory Landscape: Hear insights and analysis from experienced practitioners in our white-collar, Securities & Exchange Commission defense, antitrust, and financial institutions practices on what to expect from the Trump administration’s regulatory approach and how to prepare for it.

Gearing Up for Healthcare Workforce Conscience-Based Opt-Outs in a Second Trump Term: Learn about the implications of a recent US Supreme Court ruling on conscience protections for healthcare providers, which may lead to an increase in opt-out requests and pose significant challenges and risks for provider organizations.

Global Antitrust Update | Webinar Series – Winter 2024: Get a quick preview of how antitrust policy will develop under the new administration.

Post-Election Health Policy Priorities: Discover how to prepare your organization for policy changes under the new administration and Congress, and understand the implications of election outcomes on healthcare policy heading into the lame duck session of Congress and 2025.

Outcome of the 2024 Election and State of the Market: Review how to raise capital in light of the 2024 US presidential election and the impact of clinical data on investor valuation.

The Morning After – Impact of the US Presidential Election on the Deal Environment: Gain insight into the potential for life sciences growth under the new administration and the Republican-controlled Congress, and explore opportunities for aligning interests between the administration and the industry to leverage innovative technologies.